Clinical review 14: Pathophysiology and treatment of sexual precocity.

The complex maturational changes in both organization and activation of the hypothalamic GnRH-pituitary gonadotropin-gonadal system can be viewed as a continuum extending from its ontogeny in the fetus, through puberty, to the attainment of full sexual maturation and fertility. Restraint of the onset of puberty resides in the central nervous system (1, 2). All of the other components which include the hypothalamic GnRH pulse generator, pituitary gland, gonads, and sex steroid target organs can be activated by the appropriate stimulus at any stage between infancy and the normal age of puberty. Reactivation of the GnRH pulse generator induces increased GnRH secretion, stimulation of the pituitary gonadotropes, and subsequently increased secretion of gonadal steroids. Increased nighttime pulsatile release of LH both in frequency and amplitude and increased LH response to administration of GnRH occur with the onset of puberty. An independent process regulated by a different mechanism results in the increase i...

[1]  O. Pescovitz,et al.  Treatment of familial male precocious puberty with spironolactone and testolactone. , 1989, The New England journal of medicine.

[2]  Kaplan Sl,et al.  Recent advances in the diagnosis and management of sexual precocity. , 1988 .

[3]  J. Malley,et al.  Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. , 1986, The New England journal of medicine.

[4]  W. Crowley,et al.  Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. , 1986, Endocrine reviews.

[5]  B. Gondos,et al.  Testicular changes in gonadotropin-independent familial male sexual precocity. Familial testotoxicosis. , 1985, Archives of Pathology & Laboratory Medicine.

[6]  B. Gondos,et al.  Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. , 1985, The Journal of pediatrics.

[7]  A. Fazekas,et al.  Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. , 1985, The New England journal of medicine.

[8]  W. Crowley,et al.  Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. , 1981, The New England journal of medicine.

[9]  R. Santen,et al.  Hypothalamic hamartoma: a source of luteinizing-hormone-releasing factor in precocious puberty. , 1977, The New England journal of medicine.

[10]  M. Grumbach,et al.  Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: an example of hormonal overlap in pituitary feedback , 1960 .